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Abstract
Purpose: To investigate the presence of the variants of lysyl oxygenase (LOX) and
superoxide dismutase 1 (SOD1) genes in Brazilian patients with advanced keratoconus.
Methods: Donor genomic DNA extracted from blood samples was screened for 5’UTR,
exonic LOX, and SOD1 variants in a subset of 26 patients presenting with advanced
keratoconus (KISA > 1000% and I–S > 2.0) by Sanger sequencing. The impact of
non-synonymous amino acid changes was evaluated by SIFT, PMUT, and PolyPhen
algorithms. The Mutation Taster tool was used to evaluate the potential impact of
formation of new donor and acceptor splice sites in the promoter region of affected
volunteers carrying sequence variants. A 7-base SOD1 deletion (IVS2 + 50del7bp)
previously associated with keratoconus was screened in 140 patients presenting
classical keratoconus by gel fragment analysis, and positive samples were sequenced
for confirmation.
Results: We found an unreported missense variant in LOX exon 6 in one heterozygous
patient, leading to substitution of proline with threonine at residue 392 (p. Thr392Pro)
of LOX protein sequence. This mutation was predicted to be potentially damaging to
LOX protein. Another LOX variant, Arg158Gln, was also detected in another patient
but predicted to be non-pathogenic. Two additional new polymorphisms in LOX 5’UTR
region (–116C > T and –58C > T) were found in two patients presenting with advanced
keratoconus and were predicted to modulate or create donor/acceptor splice sites in
LOX transcripts. Additionally, SOD1 deletion was detected in one patient presenting with
severe keratoconus, not in control samples.
Conclusion: We described three novel LOX polymorphisms identified for the first time
in Brazilian patients with advanced keratoconus, as well as a previously described
SOD1 deletion strongly associated with keratoconus. A possible role of these variants
in modulating transcript levels in the cornea of affected individual requires further
investigation.
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Keratoplasty is the most frequent tissue trans-
plantation in Brazil, comprising 60% of all organ
and tissue transplantations in the country.[1] Among
these, around 50% of all performed keratoplasties
are due to keratoconus (KC), which is charac-
terized by corneal ectasia and stromal protru-
sion in a conical shape. Clinical signs of KC
usually manifest first at puberty and in young
adults leading to visual deterioration due to irreg-
ular astigmatism, myopia, and corneal scarring
in about 20% of patients.[2, 3] Although KC man-
ifests in only one eye in most patients, the
disease can progress to bilaterality in severely
affected individuals.[4] Histologically, KC is char-
acterized by impaired collagen secretion result-
ing from degeneration of keratocytes as well
as by epithelial and stromal changes leading to
disorganization of fibers involved in tissue resis-
tance and stability.[5] KC incidence is estimated
at 1/2,000 individuals in the general population,
with a prevalence of 50 to 230 cases/100,000 in
Western countries.[6] Diagnosis is usually based
on qualitative corneal topography and quantitative
videokeratography of posterior corneal surface
confirmed by a KISA index > 100%.[7] Refractive
error in KC can be corrected with glasses or
contact lenses. About 20% of patients have more
advanced disease, for which Ferrara intrastromal
corneal ring segments (Ferrara rings) are recom-
mended, along with penetrating keratoplasty in
most cases.[6, 8]
The etiology of KC is not completely understood.
The disorder has been described as multifactorial
and polygenic.[9–11] Most cases are sporadic
suggesting the role of environmental factors in
susceptible individuals, including atopic factors,
mechanical trauma, and ultraviolet (UV) light
exposure, whichmay promote corneal thinning and
tissue degradation. However, a strong association
of isolated environmental factors with KC has not
been effectively demonstrated.[4, 10, 12] Twins[13] and
family-based studies,[14] candidate gene strategies,
and genomic association studies have shown the
influence of DNA variants on KC development.
Many candidate genes regulating production or
arrangement of collagen fibers,[15–17] keratocyte
proliferation/apoptosis,[12] morphogenesis, and
regulation of oxidative stress,[18, 19] as well
as chromosomal loci bearing specific single
nucleotide polymorphisms (SNPs) have been
described in KC patients. The LOX gene, located
at 5q23.1, is among the most investigated genes
in KC.[15, 16, 20] LOX encodes a copper-dependent,
oxido-deaminase lysyl oxidase enzyme, which
plays a role in extracellular matrix maintenance
by oxidizing lysine residues and promoting the
formation of covalent cross-links of collagens
and elastin,[16] making them insoluble in the
extracellular environment.[21] Reduced LOX activity
has been detected in the cornea of patients with
KC, suggesting a significant role of this gene in
the pathogenesis of disease.[15, 22, 23] Two of the
main missense mutations, Arg158Gln (rs1800449)
and Pro159Gln (rs41407546), have been described
in both Italian and Iranian populations[16, 20]. A
role of the Arg158Gln mutation in KC has been
demonstrated in a genome-wide association study
that also identified an SNP associated with the
5’UTR region.[20] These data suggest a likely
role of the LOX gene in the development of KC.
Another candidate gene is SOD1 (superoxide
dismutase 1), which has a direct involvement
in antioxidative processes associated with
reactive oxygen species (ROS) elimination and
reduction of oxidative stress that is increased in
the corneal cells of patients with KC.[24] Located
at 21q22.11, SOD1 encodes a copper and zinc-
dependent cytoplasmic enzyme associated with
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dismutation of ROS such as superoxide radicals.[25]
There is evidence of a correlation between SOD1
variations and the development of KC, given the
presence of high levels of oxidative stress mark-
ers and/or accumulation of these markers in the
cornea of affected individuals.[26] Several studies
have described a heterozygous genomic 7-base
deletion in the intron 2 of the SOD1 gene (IVS2 +
50del7bp) in the US population which significantly
affected the conformation and function leading to
an increase in oxidative stress in the cornea.[27–29]
Two sporadic carriers of this deletion were also
detected in the Italian population,[30] and nine in the
Greek population.[29] The involvement of SOD1 in
other ocular diseases such as primary open-angle
glaucoma has also been described.[31]
Although already well studied,[32, 33] the genetic
basis of KC is still poorly understood.[34] Despite
the availability of data on the involvement of SOD1
and LOX mutations in the development of KC
in specific cohorts, little information is available
regarding Brazilian patients. A single study, using
a gene candidate approach, showed three non-
synonymous substitutions (Leu68His, Arg131Ser,
and Asp105Glu) in VSX1 gene segregating with
the phenotype in patients from the Northeast of
Brazil who presented with sporadic KC, suggesting
a role for this gene in KC development.[35] How-
ever, no additional studies are available in Brazil
regarding polymorphisms in other genes whose
involvement in KC has already been described.
The implication of SOD1 and LOX mutations on KC
development may be important risk factors for the
disease and their involvement in disease patho-
genesis depends on additional studies on different
ethnicities.[25, 33] Considering that this pathology is
considered a major public health issue in Brazil, the
aim of this study was to investigate the presence
of genetic variants in SOD1 and LOX genes in
individuals affected by advanced KC.
METHODS
Study Protocol and Participants
The research protocol was approved by the Human
Research Ethics Committee at Unifacisa (CAAE
98902918.6.0000.5175) as determined by Resolu-
tion 466/12 of the Brazilian National Health Council
and the Declaration of Helsinki. All participants
signed an informed consent form prior to their
enrolment.
Volunteer participants were recruited at an oph-
thalmology outpatient clinic (UNIFACISA/Campina
Grande) in the state of Paraiba, Brazil. The sample
included residents of Campina Grande and neigh-
boring cities (Lagoa Seca, Queimadas, Esperança
and Massaranduba). At the time of enrolment, 10
mL of whole blood were collected for later DNA
extraction and stored in a –80°C freezer at the Uni-
facisa Medical Genetics Core Laboratory (NUGEM).
Participants were included if they met minimal
topographic criteria for the diagnosis of KC: KISA
> 100% and inferior–superior asymmetry (I–S) ratio
> 1.4 diopters (D) in at least one eye.[4] Diagnostic
confirmation was based on keratometry, performed
in an Eyetech CT2000 SLE topographer (Eyetech
Equipment, São Paulo, Brazil) and Schwind Sir-
ius Scheimpflug (Eye-tech-Solutions, GmbH&Co.
Kleinostheim, Germany) tomograph. Patients with
other eye disorders (glaucoma or cataract) or those
undergoing corneal transplantationwere excluded.
Of the overall group consisting of 140 patients,
26 patients had KISA > 1000% and I–S > 2.0;
these were included in an advanced KC sub-
group. To maximize the chance of detecting the
variables with the highest pathogenic potential,
DNA sequencing for LOX gene was performed
specifically for this subgroup. A control group of 50
healthy subjects was also screened.
DNA Sequencing
Genomic DNA was extracted from blood samples.
All SOD1 and LOX gene exons were sequenced
after amplification by polymerase chain reac-
tion (PCR). For that, appropriate forward and
reverse primers were used as previously described
[29, 36, Supplementary Table 1]. The primers used for ampli-
fication of SOD1 exon 1 also spanned the proximal
5’ untranslated region (UTR), corresponding to
approximately 150 base pairs (bp) upstream from
SOD1 start codon.
PCR was run in 25 µL volumes containing 12.5
μL GoTaq Green Master Mix (Promega, USA), 5
pmol of each oligonucleotide primer, and 1 μL
resuspended DNA solution at an approximate
concentration of 200 ng/μL. Reactions were per-
formed in a thermocycler as follows: 5 min at
95°C, followed by 35 cycles (1 min at 95°C for
DNA denaturation, 1 min for primer annealing,
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and 1 min at 72°C for extension), and a final 5
min extension step at 72°C. Specificity and quality
of the amplicons were assessed in agarose gel
at 0.8% containing ethidium bromide (0.5µg/mL).
Fragments were visualized by UV light using a LPIX
transilluminator (Loccus Biotecnologia, Brazil).
To sequence PCR products, amplified exon seg-
ments were purified using the Wizard SV Gel and
PCR Clean-up System (Promega, USA). Purity was
assessed using aNano-volume spectrophotometer
(NanoVue Plus, GE), considering a 260 nm/280
nm absorbance ratio of 1.7 to 2.0 as the purity
standard. Each sequencing reaction (7.5 μL final
volume) contained 10 ng per 100 bp of specific
exons and 10 pmoles of each individual primer.
Reactionswere submitted toMyleus Biotechnology
(Belo Horizonte/MG, Brazil) for Sanger sequencing
on an ABI3130 platform. Analysis of the elec-
tropherograms was performed using Sequence
Scanner 2 v.2.0 (Applied Biosystems, EUA) and
Sequence Viewer v.7.0.2 (CLCBio, Denmark) soft-
ware. Gene sequence readings were compared
to ancestral SOD1 (ENSG00000142168) and LOX
(ENSG00000113083) sequences downloaded from
the Ensemble genome browser (www.ensembl.
org). All variations detected in samples were recon-
firmed by a new DNA extraction and sequencing.
To test for the presence of the intronic 7-base
deletion IVS2 + 50del7bp (c.169+50delTAAACAG)
in SOD1, samples were tested by PCR in 140 KC
positive patients and 120 controls, using previously
described amplification conditions.[29] Detection of
this deletion in patients involved direct visualization
of a 211 bp amplicon in a 20 x 20 cm PAGE (5%)
electrophoresis, followed by confirmatory DNA
sequencing of positive samples.
Prediction of Pathogenic Potential of Gene
Variants
To predict the impact of nonsynonymous substitu-
tions in LOX protein variants, we used SIFT (http:
//sift.jcvi.org/),[37] PolyPhen2 (http://genetics.bwh.
harvard.edu/pph2/), and PMUT (http://mmb.pcb.
ub.es/PMut/) tools.[38] These algorithms assigned
scores (i.e., probability of the substitution being
damaging) ranging from 0 to 1. Scores are gener-
ated through comparison between the ancestral
amino acid sequence and the variant sequence
(missense mutation). In the SIFT platform, a score
up to 0.5 indicates a potentially pathogenic variant,
whereas higher scores indicate a benign sub-
stitution. Conversely, the PMUT and PolyPhen2
platforms use values close to zero indicating a
benign variant, with values closer to 1 suggesting
a pathogenic variant.
To predict the impact of 5’-UTR LOX polymor-
phisms as pathogenic or neutral, the web-based
Mutation Taster application (www.mutationtaster.
org) was used. PhyloP and phastCons tools were
also used to verify the grade of conservation of
SNPs. Briefly, phastCons values range from 0 to
1 and reflect the probability that each nucleotide
belongs to a conserved regulatory element, based
on multiple alignment of genome sequences of
46 different species, as well as alterations in
neighboring nucleotides. Values closer to 1 indi-
cate high residue conservation. For phyloP (values
ranging from –14 to +6), the same method is
used without considering neighboring nucleotides.
Positive values are attributed to conserved sites.
Additionally, the application predicts the expected
impact of altering or creating non-canonical splice
sites (including those detected in the 5’-UTR region
of the gene) using an integrated version of the
NNSplice software. Changes in typical splice sites
may become stronger or weaker. New splices
are indicated by a confidence score higher than
0.3. Information is also provided on the genomic
position of the splice site, the prediction scores for
reference and mutated sites, and a short sequence
indicating the intron/exon border.
In addition, to assess the amino acid conser-
vation, primary amino acid sequences coded for
human SOD1 and LOX genes were aligned to mul-
tiple ortholog gene sequences in phylogenetically
close organisms downloaded from Ensembl (www.
ensembl.org), using the ClustalW Omega software
(http://www.ebi.ac.uk/Tools/msa/clustalo/).
RESULTS
Of the 26 patients with advanced KC selected for
the present study, 16 (61.5%)were female.Mean age
was 28.5 years (SD ± 10.6), and mean KISA% index
was 921.5 (± 1153.17) for the right eye and 1,451.5 (±
607.6) for the left eye. Mean I–S was 6.60 D (± 3.13)
for the right eye and 6.83D (± 3.35) for the left eye.
Topography data are summarized in Table 1.
The sequencing of LOX coding region revealed
two SNPs. The first variant is a cytosine to thymine
transition at position 773 (c.773 C > T) [Figure 1A],
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Table 1. Mean KISA and I–S indexes in Brazilian patients with keratoconus
Eye KISA (%) I–S
Mean SD Mean SD
Right 921.52 607.6 6.6 3.13
Left 1,451.48 1,153.17 6.83 3.35
KISA, keratoconus percentage index; I-S, inferior-superior value; SD, standard deviation
Table 2. Predicted variant impact on LOX protein conformation analyzed by PMUT, SIFT, and PolyPhen2 algorithms. Allelic
frequencies are indicated.
Residue PMUT PolyPhen2 SIFT TGP frequency
R158Q 0.11 0.000 0.21 0.157 (16%)
T392P 0.68 0.087 0.02 ND
TGP, 1000 Genome project; ND, not described
Table 3. Mutation Taster analysis of SOD1 promoter nucleotide variations
Variant Effect WT score Variant score Position phyloP phastCons
–58 C > T Acc increased 0.43 0.52 g.90 0.216 0.015
–58 C > T Acc increased 0.24 0.32 g.97 0.216 0.015
–58 C > T Donor gained NA 0.38 g.84 0.216 0.015
(–116 C > T) Acceptor gained NA 0.32 g.44 1.383 0.058
–58 C > T Acc increased 0.43 0.52 g.90 0.216 0.015
–58 C > T Acc increased 0.24 0.32 g.97 0.216 0.015
–58 C > T Donor gained NA 0.38 g.84 0.216 0.015
(–116 C > T) Acceptor gained NA 0.32 g.44 1.383 0.058
Table 4. Supporting Material - PCR Primers and annealing conditions used in this work
Primer Forward (5’-3’) Reverse (5’-3’) Tf (bp) Tm (°C)
LOX – P1a GAGACTGAGATACCCGTGCT AGCGGTGACTCCAGATGA 474 58
LOX – P1b TCACAGTACCAGCCTCAGC ATAGCTGGGGACCAGGTG 500 60
LOX– P2 TTTTCACATTGCTTTGCAGT GCTCTTGTCCCACTTCCTAA 398 58
LOX – P3 TAGTTGGGAAAGGAGGATTG GCAATTTTCTCCCTTCAGGT 355 58
LOX – P4 GACTTATGTCCTGGGGAAAA GATAAAAATGTGTGTGCTCTTCA 441 58
LOX – P5 GGAGGTGCTATAAGGCTGAG TTGCTTCCAATACCATGATT 370 58
LOX – P6 TTCAGGGGAAAATATGCAGT TGCTTACAAGAAAGCTGCTG 394 58
LOX - P7 CTTAGGTGGAGGGAAACTGT AAGTCATTTTGGCTCATTCA 485 58
SOD1 - P1 CTCCACATTTCGGGGTTCT ACCCGCTCCTAGCAAAGGT 450 58
SOD1 - P2 CCATCTCCCTTTTGAGGACA CGACAGAGCAAGACCCTTTC 426 58
SOD1 - P3 TGATGCAGGTCAGCACTTTC AAAAGCATTCCAGCATTTGG 344 58
SOD1 - P4 CCATCTTTCTTCCCAGAGCA GAAACCGCGACTAACAATCAA 386 58
SOD1 - P5 TTTGGGTATTGTTGGGAGGA TCTGTTCCACTGAAGCTGTTT 675 59
SOD1 del CAGAAACTCTCTCCAACTTTGC GAGGGGTTTTAACGTTTAGGG 218 59
PCR, polymerase chain reaction
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observed in three patients – two heterozygotes
(C/T) and one homozygote (T/T). This variant
leads to replacement of arginine with glutamine
at residue 158 (p. Arg158Gln) of the primary LOX
amino acid sequence. The second variant is an
adenine to thymine substitution at position 1474
(c.1474T > A) of LOX exon 6 [Figure 1B]. This
variant leads to a threonine to proline substitution
at residue 392 (p. Thr392Pro) of the primary LOX
protein sequence. Thr392Pro is a previously unre-
ported mutation of the LOX gene. None of these
variants were found in control samples.
The assessment of the Thr392Pro mutation
using the PMUT and PolyPhen platforms yielded
scores of 0.68 and 0.087, respectively, with 85%
probability of pathogenicity [Table 2]. For the
Arg158Gln variant, the PMUT score was 0.11, indi-
cating a 95% likelihood of this being a neutral
mutation, which was confirmed by a low PolyPhen
score. The results obtained with SIFT analysis
produced scores of 0.02 and 0.21 for Arg158Gln
and Thr392Pro, respectively, confirming a delete-
rious effect of Thr392Pro and a neutral impact of
Arg158Gln.
Regarding the comparison with ancestral
residues to determine amino acid conservation
across different species through ClustalW Omega
alignment, the two amino acids were found to be
relatively conserved. Threonine at position 392
is greatly conserved in hominids, but not in more
phylogenetically distant species [Figure 2].
SOD1 intronic 7-base deletion was detected in
one patient [Figure 3A]. The patient was diagnosed
with advanced KC, presenting KISA values of 4,083
and 3,574 diopters and I–S values of 8,14 and
9,92, for right and left eyes, respectively. This
variant was not detected in any of the non-affected
individuals. The sequencing of this region in the
carrier showed an electropherogram pattern that
suggests a concatenated overlapping of the wild-
type and deleted alleles, a typical pattern observed
in individuals who are heterozygote for deletion
[Figure 3B].
In addition, we observed the presence of two
base polymorphisms at the untranslated 5’ region
(5’-UTR) of SOD1 in two affected individuals. The
two variants involved replacement of thymine with
cytosine, one at position –116 (–116C > T) and the
second at position –58 (–58C > T), both located
at the SOD1 promoter region. Electropherograms
for these variants showed heterozygous point
mutations in both patients [Figure 4]. Variant –
58C > T had already been described in the
dbSNP (rs906695375) databank, but not in 1000
Genomes. In the present work, this variant was
detected in a proband with KISA score of 1,294%
and I–S of 4.68 in the right eye and KISA of 2,592%
and I–S score of 7.24 in the left eye. No other
variants were found in SOD1 coding region in the
26 patients analyzed. The alignment of the human
SOD1 promoter region sequence with that of other
hominids show conservation of these residues over
evolution [Figure 5].
An analysis of the impact of variants in the SOD1
gene promoter region showed a significant conser-
vation score (0.216) with phyloP analysis for the –
58C > T variant, as well as for the upstream (0.5)
and downstream (1.771) flanking region phastCons
analysis, which also showed significance for this
variant, with values slightly higher than zero [Table
3]. A positive modulation by variant –58C > T
of the splice acceptor sites predicted at positions
90 and 97 of the gene, with scores of 0.52 and
0.32, respectively, was suggested. In addition, the
analysis suggests the creation of a new ectopic
splice donor site at position 84, with a score of
0.38. Analysis of variant –116C > T showed a new
splice acceptor site at position 44, with a score
of 0.32. Significant conservation scores were also
observed for phyloP (1.383) and phastCons (0.058).
DISCUSSION
Cornea has been the most transplanted tissue
in Brazil since the late 1990s, with KC among
the main etiologies.[39, 40] Molecular and link-
age studies have suggested multiple candidate
genes that might underlie the development of
KC.[32] In the present work, we found two non-
synonymous mutations in LOX, namely Arg158Gln
and Thr392Pro, and an intronic SOD1 deletion pre-
viously associated with KC development. Variant
Thr392Pro in the LOX gene is a novel missense
mutation that has not been previously described;
this mutation was found in 1 out of 26 patients with
advanced KC. The scores obtained with compu-
tational algorithms suggest a deleterious impact
of this substitution on protein stability resulting
from the replacement of threonine (aliphatic open
side chain) with proline. Proline is an amino acid
with non-polar side chain, therefore not capable of
ionization and hydrogen bonding, and featuring a
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Figure 1. Electropherograms showing R158Q (c.773 C > T) (A) and T392P (c.1474T > A) (B) variants. Genotypes are indicated, and
dotted vertical lines indicate peak location for each alteration. Sequencing of T392P variant was obtained using reverse primer.
Figure 2. Conservation of LOX primary amino acid sequence in several species. Positions of residues R158 and T392 relative to
Homo sapiens LOX protein are indicated.
secondary rather than a primary amino group. This
suggests that the substitution may possibly affect
protein folding and compromise cellular function.
In addition, threonine was conserved in hominids,
which supports the notion that this residue is
important for normal LOX function. Nevertheless,
the non-conserved amino acid in Felis catus and
Bos taurus is a serine, which presents a side
chain with similar biochemical properties (both
containing aliphatic hydroxyl groups), indicating an
essential role in the secondary LOX structure of all
species considered.
We found themissense Arg158Gln variant in LOX
gene, detected in 3 of the 26 patients analyzed,
with one being homozygous and two heterozygous
for this mutation. This substitution has also been
described (rs1800449) in other ethnic groups.[16, 20]
However, a meta-analysis did not find sufficient
evidence in the literature to associate this SNP with
the development of KC.[15] In fact, in silico assess-
ments performed with PMUT, SIFT, and PolyPhen-
2 algorithms produced scores indicating this as a
neutral, non-pathogenic substitution. This finding
is confirmed by the high frequency of the T allele,
found in 16% of the world population according to
the 1000 Genome Project database. In addition,
the glutamine for arginine (both of which have
open chains of similar size) substitution is well-
tolerated because of the similar physicochemical
characteristics of these amino acids and does not
substantially interfere with LOX protein folding. The
alignment of LOX sequences of phylogenetically
close species also revealed non-conservation of
this arginine. Therefore, the present findings sug-
gest low impact of the Arg158Gln variant on LOX
function.
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Figure 3. Detection of the IVS2 + 50del7bp deletion in SOD1 gene in one patient affected with advanced keratoconus. (A)
PAGE electrophoresis showing a subset of patients tested for the deletion (numbers indicated above). Amplicons of 218 pb
(normal) and 211 pb (deleted) fragments are indicated by black arrows. A 1 kb DNA ladder shows the 300 pb reference fragment
(smaller fragments are not shown). (B) Electropherograms of the deletion region from normal and affected patients. (C) Corneal
topographies of KC patient carrying the SOD1 deletion. PB, base pairs; KB, kilobases; OD, right eye; OE, left eye.
For the first time, we identified the IVS2 +
50del7bp deletion in SOD1 gene in the Brazilian
population. This variant was detected in 1 patient
with severe KC out of 140 KC affected volunteers,
which was absent in 120 healthy controls. The
literature has described significant association of
this deletion with KC development both in familial
and sporadic cases of various ethnicities. A study
conducted by Udar et al reported a haplotype-
independent segregation of this deletion in two
non-related American families presenting an auto-
somal dominant form of KC.[27] This finding sug-
gests a likely autonomous effect of SOD1 IVS2 +
50del7bp on KC pathogenesis. An mRNA analysis
of SOD1 carrying this deletion showed, in addition
of the wild-type transcript, two splice variants lack-
ing exon 2, or both exon 2 and 3 simultaneously,
which exclude SOD1 protein active site and lead
to a loss of function protein.[27] Another study
with 33 Greek patients found that homozygote
carriers for this deletion were significantly overrep-
resented among KC patients compared to healthy
subjects.[29] We also verified a similar frequency of
IVS2 + 50del7bp allele found with other studies.[30]
We believe that this specific SOD1 deletion, yet
with a low frequency in all cohorts studied, rein-
forces IVS2 + 50del7bp deletion as a key genetic
alteration highly associated with KC in different
populations.
We also detected two SNPs in the untranslated
5’ region of SOD1, both characterized by replace-
ments of cytosine with thymine at positions –58
and –116 in two different patients. There have been
no reports in the literature of any of the two variants
described in the present work. In silico analysis
showed scores indicating increased activity of
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Figure 4. Electropherograms showing 5’UTR polymorphisms located at positions –116C > T (A) and –58C > T (B) relative to SOD1
ATG start site. Sequencing was performed using reverse primer.
Figure 5. DNA sequence alignment of SOD1 5’UTR sequences from different species. Conserved positions of residues –116 and
–58 relative to Homo sapiens sequence are indicated.
splice acceptors in the presence of variant –58C
> T. In addition, these scores also showed high
probability of these variations having a pathological
impact on SOD1 activity because of the creation
of donor (–58C > T) and acceptor (–116C > T)
splice sites. This is a noteworthy finding, since
alterations in the SOD1 promoter region sequence
may cause a decrease in protein expression, as
shown for other disorders.[41, 42] The SOD1 protein
neutralizes excess ROS in the cell, and ROS lev-
els are increased in patients with KC.[43–45] Low
levels of SOD1 enzyme can also result from gene
mutations.[28] It is possible that these variants may
be related to changes in the function of this gene
in patients with KC, considering that these are
highly conserved residues and the predicted splice
sites may influence the normal processing points
at the exon–intron boundaries in the gene. We
believe that these 5’-UTR variants may modulate
SOD1 gene expression in KC patients, although
additional in vitro studies involving cloning of the
SOD1 gene, with a focus on the variants described
in the present study and analysis of the impact of
these variants on transcription rates, are essential
to confirm the involvement of these polymorphisms
in the pathophysiology of KC.
In conclusion, we report a novel Thr392Pro with
potential damaging effect to LOX protein in a
Brazilian patient presenting advanced KC, as well
as a previously described Arg158Gln variant. We
also detected a previously KC associated SOD1
IVS2 + 50del7bp deletion in another patient with
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severe KC, and two SNPs located in SOD1 5’UTR
with still unclear involvement in KC pathogenesis.
SOD1 and LOX variants found in Brazilian unrelated
KC patients suggests a genetic contribution to
disease onset and progression, although further
studies will be key to validate their impact on
gene transcription and protein function. In addi-
tion, variant screening in larger samples will be
essential to evaluate the real contribution of these
polymorphisms to KC pathophysiology in Brazilian
population.
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